Morgan Stanley has upgraded its view on China equities to overweight, pointing to positive developments including a clear path towards a reopening from COVID-19 – even if bumps in the road continue to pressure corporate earnings into early 2023. The bank said in a research note on Monday that China is attractive in terms of valuations on a price-to-book (PB)…
To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
Subscriber Only Content
This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.
Need help? Please see our FAQ Guide or email [email protected]
Have a confidential tip? Get in touch [email protected]
